Current status of therapy in autoimmune liver disease.

@article{Hirschfield2009CurrentSO,
  title={Current status of therapy in autoimmune liver disease.},
  author={Gideon M. Hirschfield and Nadya Al-Harthi and Elizabeth Jenny Heathcote},
  journal={Therapeutic advances in gastroenterology},
  year={2009},
  volume={2 1},
  pages={11-28}
}
Therapeutic strategies for autoimmune liver diseases are increasingly established. Although proportionately uncommon, specialist centers have with time refined the best approaches for each disease, based on an improved understanding of the spectrum of presentation. The major treatment aims are to prevent end-stage liver disease and its associated complications. As a result of drugs such as ursodeoxycholic acid, predniso(lo)ne and azathioprine, both primary biliary cirrhosis and autoimmune… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS